The Alliance for Connected Care and other leading organizations called on the Biden Administration to make modifications to the Drug Enforcement Administration’s (DEA)  proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluationto ensure more flexible prescribing limitations for providers when a controlled substance is offered by a highly-trained clinician in conjunction with an ongoing mental health treatment plan.

To read the final letter, see below or click here.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [138.58 KB]